Myeloma patient NK cell dysfunction is driven by impaired immune signalling

Published: 20 April 2020| Version 1 | DOI: 10.17632/tw2xm5wwg3.1
Contributor:
Simon Keam

Description

Normalised RNAseq data from FACS sorted healthy donor and patient Natural killer cells with either CD57- or CD57+ expression

Files

Institutions

Peter Mac at the Victorian Comprehensive Cancer Centre

Categories

Immunology, Cancer, Multiple Myeloma, Patient, Natural Killer Cell

Licence